Table 4 Summary of median and 1–3–5 years actuarial data for overall survival and progression free survival for the 3DCRT and VMAT cohorts
Median time [years] | p | 1-year | 3-years | 5-years | |
|---|---|---|---|---|---|
Progression free survival | |||||
3DCRT | 0.99 ± 0.07 (CI95:range 0.9–1.1) | 0.02 | 49.6 ± 4 % | 19.1 ± 3.1 % | 11.2 ± 2.5 % |
VMAT | 1.29 ± 0.13 (CI95:range 1.01–1.5) | 60.8 ± 3.8 % | 29.7 ± 4.6 % | 29.7 ± 4.6 % | |
Overall survival | |||||
3DCRT | 1.21 ± 0.09 (CI95:1.03–1.3) | <0.01 | 63.3 ± 3.8 % | 21.5 ± 3.3 % | 10.6 ± 2.5 % |
VMAT | 1.56 ± 0.09 (CI95:1.37–1.74) | 73.4 ± 3.5 % | 30 ± 4.6 % | 24.2 ± 5.4 % | |